×
About 2,988 results

ALLMedicine™ Amniocentesis Center

Research & Reviews  956 results

Residual risk of noninvasive prenatal screening in pregnancies with ultrasound anomalies.
https://doi.org/10.1016/j.jogoh.2022.102515
Journal of Gynecology Obstetrics and Human Reproduction; Lu B, Yin L et. al.

Nov 29th, 2022 - To discuss the residual risk (RR) of noninvasive prenatal screening (NIPS) for the mothers with fetal ultrasound abnormalities. 880 pregnant women with fetal ultrasound abnormalities accepted prenatal diagnosis by chromosomal microarray analysis (...

Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection an...
https://doi.org/10.1002/uog.26128
Ultrasound in Obstetrics & Gynecology : the Official Jour... Chatzakis C, Sotiriadis A et. al.

Nov 23rd, 2022 - CMV DNA is detectable in the amniotic fluid collected by amniocentesis, in cases that the fetus has been infected. However, in the literature there are reported cases of congenital neonatal CMV infection with a negative amniocentesis. The aim of t...

SOGC Guideline Retirement Notice No. 3.
https://doi.org/10.1016/j.jogc.2022.09.005
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou...

Nov 22nd, 2022 - These documents have been archived because they contain outdated information. They should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines. Prenatal Screening for ...

The management of congenital adrenal hyperplasia during preconception, pregnancy, and p...
https://doi.org/10.1007/s11154-022-09770-5
Reviews in Endocrine & Metabolic Disorders; Maher JY, Gomez-Lobo V et. al.

Nov 19th, 2022 - Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders of steroidogenesis of the adrenal cortex, most commonly due to 21-hydroxylase deficiency caused by mutations in the CYP21A2 gene. Although women with CAH have decreas...

Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
https://doi.org/10.1111/trf.17177
Transfusion Maisonneuve E, Sohier Lepine M et. al.

Nov 10th, 2022 - Pyruvate Kinase (PK) deficiency is the most common enzyme defect of glycolysis, leading to congenital hemolytic anemia, which can occur during the neonatal period. We report the prenatal management of fetal anemia related to PK deficiency in a fam...

see more →

Guidelines  10 results

Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of is...
https://doi.org/10.1016/j.ajog.2021.06.079
American Journal of Obstetrics and Gynecology; , Prabhu M et. al.

Jun 26th, 2021 - Soft markers were originally introduced to prenatal ultrasonography to improve the detection of trisomy 21 over that achievable with age-based and serum screening strategies. As prenatal genetic screening strategies have greatly evolved in the las...

Directive clinique no 409 : Tests diagnostiques fœtaux intra-utérins en cas d'infection...
https://doi.org/10.1016/j.jogc.2020.10.006
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wilson RD

Dec 15th, 2020 - La présente directive clinique révisée met à jour les renseignements sur la prestation de soins aux femmes atteintes d'une infection virale chronique devant se soumettre à un test diagnostique fœtal intra-utérin. Femmes atteintes d'une infection v...

Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral In...
https://doi.org/10.1016/j.jogc.2020.09.007
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wilson RD

Dec 15th, 2020 - This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive s...

Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal...
https://doi.org/10.1016/j.jogc.2020.11.003
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Douglas Wilson R, Van Mieghem T et. al.

Nov 20th, 2020 - This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Women who are pregnant or may become pregnant. Neural tube defect screening should be of...

Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders.
https://doi.org/10.1097/AOG.0000000000001438
Obstetrics and Gynecology;

Apr 23rd, 2016 - Prenatal genetic diagnostic testing is intended to determine, with as much certainty as possible, whether a specific genetic disorder or condition is present in the fetus. In contrast, prenatal genetic screening is designed to assess whether a pat...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  82 results

IDENTIFY Study: Natural History of Maternal Neoplasia
https://clinicaltrials.gov/ct2/show/NCT04049604

Oct 5th, 2022 - Background: Starting in 2011, analysis of circulating cell-free DNA (cfDNA) in the blood of pregnant women began to be offered clinically as a prenatal screen for trisomies 13, 18, and 21. Owing to its superior sensitivity and positive predictive ...

Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered
https://clinicaltrials.gov/ct2/show/NCT05182242

Aug 30th, 2022 - The discovery of congenital malformations and/or non-specific signs by ultrasound (5% of pregnancies) represents a real medical challenge. Their prognosis is variable depending on the underlying etiology, ranging from acquired fetopathies to rare ...

a Comparison Between the Effects of Crystalloids and Colloids on Lung Ultrasound
https://clinicaltrials.gov/ct2/show/NCT05505708

Aug 18th, 2022 - Hypertensive disorders are the most common complications of pregnancy. They occur in 6-8% of pregnancies and account for approximately 15% of maternal deaths in the United States Pre-eclampsia is a pregnancy-specific syndrome of unknown etiology t...

Fetal Genome Profiling Via Trophoblast Cells
https://clinicaltrials.gov/ct2/show/NCT03832634

Jul 28th, 2022 - The primary purpose of the study is to validate trophoblast retrieval and isolation from the cervix (TRIC) as a means of reliable non invasive prenatal genetic diagnosis (for both chromosomal abnormalities, as well as single gene defects). The stu...

NGS in the Diagnosis of Neonatal Diseases
https://clinicaltrials.gov/ct2/show/NCT05476055

Jul 27th, 2022 - As health care has improved, genetic diseases have become the leading cause of infant death in hospitalized neonatal. However, due to extensive clinical and genetic heterogeneity, differential diagnosis of all known genetic disorders is often a ch...

see more →

News  108 results

Lasker Awardee Pioneered Prenatal DNA Testing
https://www.medscape.com/viewarticle/981863

Oct 4th, 2022 - For Yuk Ming Dennis Lo, BM BCh, DPhil, a 1996 paper showing the detection of tumor DNA in blood plasma would prove a turning point. Since the 1960s, clinicians had been searching for a way to glimpse into a fetus' genetic makeup without disturbing...

How Abortion Rules Affect Prenatal Genetic Screening
https://www.medscape.com/viewarticle/976574

Jul 5th, 2022 - Ann was 15 weeks pregnant with her fourth child when the results of her prenatal genetic test came back last August. The test suggested that her daughter, whom she and her husband planned to name Juliet, was missing one of her two X chromosomes — ...

FDA Issues Warning on Prenatal Genetic Tests
https://www.medpagetoday.com/obgyn/generalobgyn/98285

Apr 19th, 2022 - The FDA warned in a safety communication that non-invasive prenatal tests (NIPT) are screening tests -- not diagnostic tests -- and patients and healthcare providers may make inappropriate healthcare decisions based on their results. The agency sa...

Clinical Edge Journal Scan Commentary: Prenatal Testing February 2022
https://www.mdedge.com/obgyn/article/251064/prenatal-testing/clinical-edge-journal-scan-commentary-prenatal-testing
Ryan Longman, MD

Jan 24th, 2022 - Ryan Longman, MD The field of obstetrics has always aimed to optimize the ability to screen pregnancies for aneuploidy; trisomy 21, trisomy 18, and trisomy 13. A recent study by Saito et al.

Low Risk of Fetal Chromosome Abnormality After Mosaic-Embryo Transfer
https://www.medscape.com/viewarticle/962176

Nov 5th, 2021 - NEW YORK (Reuters Health) - Embryos classified as mosaic are capable of producing healthy babies and should be considered for transfer when a euploid embryo is not available, say fertility specialists. Mosaic-embryo transfer (MET) following preimp...

see more →

Patient Education  34 results see all →